DrugsControl Media Services

News Detail

Maintaining Standard of Drugs of ‘Paramount Importance’, DCGI Tells States & UTs (27-04-2023)

New Delhi, 27 April 2023: Maintaining the standard of made-in-India medicines is of ‘paramount importance’, the country’s apex drug regulator has told states and Union Territories amid fixing quality issues of the Indian pharmaceutical industry.

The m......
View Details

Source : News 18
active pharmaceutical ingredients DCGI paracetamol Ministry of Health and Family Welfare uzbekistan Gambia United states DCGI Rajeev Singh Raghuvanshi Indian pharmaceutical industry

Related News